Impaired awareness of movement disorders in Parkinson's disease

Brain and Cognition

Volumn 72, Issue 3, 2010, Pages 337-346

  Amanzio, Martina ^a   Monteverdi, Silvia ^a   Giordano, Alessandra ^a   Soliveri, Paola ^b   Filippi, Paola ^c,d   Geminiani, Giuliano ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c Azienda Sanitaria Ospedaliera San Luigi Gonzaga   (Italy)

^d MARIA VITTORIA HOSPITAL   (Italy)

Author keywords

Awareness of movement disorders; Dyskinesia; Executive functions; Hypokinesia; Parkinson's disease

Indexed keywords

BENSERAZIDE; CABERGOLINE; CARBIDOPA; LEVODOPA; PRAMIPEXOLE; ROPINIROLE;

ADL DISABILITY; ADULT; AGED; ARTICLE; AWARENESS; BRADYKINESIA; BRAIN CORTEX; BRAIN DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DYSKINESIA; FEMALE; GLOBAL AWARENESS OF MOVEMENT DISORDERS; HUMAN; HYPOKINESIA; MALE; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; ON OFF PHENOMENON; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RATING SCALE;

ADULT; AGED; AGNOSIA; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; AWARENESS; FEMALE; HUMANS; HYPOKINESIA; LEVODOPA; MIDDLE AGED; MOVEMENT DISORDERS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SELF CONCEPT; STATISTICS, NONPARAMETRIC;

EID: 77249161126     PISSN: 02782626     EISSN: 10902147     Source Type: Journal    
DOI: 10.1016/j.bandc.2009.10.011     Document Type: Article

References (80)

1. Aarsland D., Cummings J.L., and Larsen J.P. Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease. International Journal of Geriatric Psychiatry 16 (2001) 184-191
2. Aarsland D., Larsen J.P., Lim N.G., Janvin C., Karlsen K., Tandberg E., et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 67 (1999) 492-496
3. Aarsland D., Litvan I., and Larsen J.P. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neuroscience 13 (2001) 42-49
4. Agid Y., Ruberg M., Javoy-Agid F., Hirsch E., Raisman-Vozari R., Vyas S., Faucheux B., et al. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?. Advances in Neurology 60 (1993) 148-164
5. Alexander G.E., DeLong M.R., and Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 9 (1986) 357-381
6. Amanzio M., and Torta D.M.E. Unawareness of deficits in Alzheimer's disease through a biopsychosocial perspective. In: Larson C.B. (Ed). Metacognition: New research developments (2009), Nova Science Publishers, Hauppauge, New York 239-253
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), APA, Washington, DC
8. Baddeley A. Working memory (1986), Oxford University Press, New York
9. Bisiach E., and Geminiani G. Anosognosia related to hemiplegia and hemianopia. In: Prigatano G., and Schacter D.L. (Eds). Awareness of deficit after brain injury (1991), Oxford University Press, New York 17-39
10. Bisiach E., Vallar G., Perani D., Papagno C., and Berti A. Unawareness of disease following lesions of the right hemisphere: Anosognosia for hemiplegia and anosognosia for hemianopsia. Neuropsychologia 24 (1986) 471-482
11. Canter G.J., De Latorre R., and Mier M. A method for evaluating disability in patients with Parkinson's disease. Journal of Nervous and Mental Disease 133 (1961) 143-152
12. Carter J.H., Stewart B.J., Archbold P.G., Inoue I., Jaglin J., Lannon M., et al. Living with a person who has Parkinson's disease: The spouse's perspective by stage of disease. Parkinson's study group. Movement Disorders 13 1 (1998) 20-28
13. Claridge G.S. Personality and arousal. A psychophysiological study of psychiatric disorders (1967), Pergamon Press
14. Cohen H., and Cohen D. What may be gained from neuropsychological investigations of tardive dyskinesia?. Brain Cognition 23 1 (1993) 1-7
15. Cools R., Barker R.A., Sahakian B.J., and Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cerebral Cortex 11 12 (2001) 1136-1143
16. Czernecki V., Pillon B., Houeto J.L., Pochon J.B., Levy R., and Dubois B. Motivation, reward and Parkinson's disease: Influence of dopatherapy. Neuropsychologia (2002) 2257-2267
17. Deckel A.W., and Morrison D. Evidence of a neurologically based "denial of illness" in patients with Huntington's disease. Archives of Clinical Neuropsychology 11 4 (1996) 295-302
18. Fahn S., and Elton R.L. Unified Parkinson's disease rating scale. In: Fahn C.D., Marsden M., Goldstein M., and Calne D.B. (Eds). Recent developments in Parkinson's disease (1987), McMillan Healthcare Information, Florham, New York
19. Flowers F.A., and Robertson C. The effect of Parkinson's disease on the ability to maintain a mental set. Journal of Neurology, Neurosurgery and Psychiatry 48 (1985) 517-529
20. Folstein M.F., Folstein S.E., and Brandt J. Huntington's disease. In: Cummings J.L. (Ed). Subcortical dementia (1990), Oxford, New York
21. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state. Journal of Psychiatric Research 12 (1975) 189-198
22. Gehring W.J., and Knight R.T. Prefrontal-cingulate interactions in action monitoring. Nature Neuroscience 3 5 (2000) 516-520
23. Giovannoni G., O'Sullivan J.D., Turner K., Manson A.J., and Lees A.J. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. Journal of Neurology, Neurosurgery and Psychiatry 68 (2000) 423-428
24. Godefroy O., Rousseaux M., Pruvo J.P., Cabaret M., and Leys D. Neuropsychological changes related to unilateral lenticulostriate infarcts. Journal of Neurology, Neurosurgery and Psychiatry 57 4 (1994) 480-485
25. Gotham A.M., Brown R.G., and Marsden C.D. "Frontal" cognitive function in patients with Parkinson's disease "on" and "off" levodopa. Brain 111 (1988) 299-321
26. Hamilton M.A. The assessment of anxiety states by rating. British Journal of Medical Psychology 32 (1959) 50-55
27. Hamilton M.A. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23 (1960) 56-62
28. Healton E.B., Navarro C., Bressman S., and Brust J.C. Subcortical neglect. Neurology 32 7 (1982) 776-778
29. Ho A.K., Robbins A.O., and Barker R.A. Huntington's disease patients have selective problems with insight. Movement Disorders 21 3 (2006) 385-389
30. Hoehn M.M., and Yahr M.D. Parkinsonism: Onset, progression and mortality. Neurology 17 (1967) 427-442
31. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. The accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study. Journal of Neurology, Neurosurgery and Psychiatry 55 (1992) 181-184
32. Hume W.I., and Claridge G.S. A comparison of two measures of "arousal" in normal subjects. Life Science 4 (1965) 545-553
33. Isella V., Melzi P., and Grimaldi M. Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease. Movement Disorders 17 (2002) 366-371
34. Jacome D.E. Subcortical prosopagnosia and anosognosia. American Journal of Medical Science 292 6 (1986) 386-388
35. Jellinger K. Overview of morphological changes in Parkinson's disease. Advances in Neurology 45 (1987) 1-18
36. Kimberg D.Y., D'Esposito M., and Farah M.J. Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 8 16 (1997) 3581-3585
37. Kish S.J., Shannak K., and Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. New England Journal of Medicine 318 14 (1988) 876-880
38. Ko J.H., Monchi O., Ptito A., Petrides M., and Strafella A.P. Repetitive transcranial magnetic stimulation of dorsolateral prefrontal cortex affects performance of the Wisconsin card sorting task during provision of feedback. International Journal of Biomedical Imaging 2008 (2008) 143238
39. Koller W.C., Hutton J.T., Tolosa E., and Capilldeo R. Immediate-release and controlled-release carbidopa/levodopa in PD: A 5 years randomized multicenter study. Carbidopa/Levodopa Study Group. Neurology 53 (1999) 1012-1019
40. Laiacona M., Inzaghi M.G., De Tanti A., and Capitani E. Wisconsin Card Sorting test: A new global score, with Italian norms, and its relationship with the Weigl sorting test. Neurological Science 21 (2000) 279-291
41. Lazzarino L.G., and Nicolai A. Hemichorea-hemiballism and anosognosia following a contralateral infarction of the caudate nucleus and anterior limb of the internal capsule. Rivista di Neurologia 61 1 (1991) 9-11
42. Leritz E., Loftis C., Crucian G., Friedman W., and Bowers D. Self-Awareness of deficits in Parkinson disease. The Clinical Neuropsychologist 18 (2004) 352-361
43. Levy R., and Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cerebral Cortex 16 (2006) 916-928
44. Lichter D.G. Movement disorders and frontal-subcortical circuits. In: Lichter D.G., and Cummings J.L. (Eds). Frontal-subcortical circuits in psychiatric and neurological disorders (2000), The Guilford Press, New York 260-313
45. Lopez O.L., Becker J.T., Somsak D., Dew M.A., and DeKosky S.T. Awareness of cognitive deficits and anosognosia in probable Alzheimer's disease. European Journal of Neurology 34 (1994) 277-282
46. Lumme V., Aalto S., Ilonen T., Någren K., and Hietala J. Dopamine D2/D3 receptor binding in the anterior cingulate cortex and executive functioning. Psychiatry Research 156 1 (2007) 69-74
47. Luu P., Flaisch T., and Tucker D.M. Medial frontal cortex in action monitoring. Journal of Neuroscience 20 1 (2000) 464-469
48. Marras C., and Lang E. Measuring motor complications in clinical trials for early Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 74 (2003) 143-146
49. Martínez-Martín P., Benito-León J., Alonso F., Catalán M.J., Pondal M., and Zamarbide I. Health-related quality of life evaluation by proxy in Parkinson's disease: Approach using PDQ-8 and EuroQoL-5D. Movement Disorders 19 3 (2004) 312-318
50. Mattay V.S., Callicott J.H., Bertolino A., Heaton I., Frank J.A., Coppola R., et al. Effects of dextroamphetamine on cognitive performance and cortical activation. NeuroImage 12 3 (2000) 268-275
51. McGlynn S.M., and Kaszniak A.W. When metacognition fails: Impaired awareness of deficit in Alzheimer's disease. Journal of Cognitive Neuroscience 3 (1991) 183-189
52. McGlynn S.M., and Schacter D.L. Unawareness of deficit in neuropsychological syndrome. Journal of Clinical and Experimental Neuropsychology 11 (1989) 143-205
53. McNamara P., Obler L.K., Au R., Durso R., and Albert M.L. Speech monitoring skills in Alzheimer's disease, Parkinson's disease, and normal aging. Brain and Language 42 (1992) 38-51
54. Mehta M.A., Owen A.M., Sahakian B.J., Mavaddat N., Pickard J.D., and Robbins T.W. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. Journal of Neuroscience 20 6 (2000) 240-265
55. Monchi O., Petrides M., Mejia-Constain B., and Strafella A.P. Cortical activity in Parkinson disease during executive processing depend on striatal involvement. Brain 130 (2007) 233-244
56. Monchi O., Petrides M., Petre V., Worsley K., and Dagher A. Wisconsin Card Sorting revisited: Distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. Neuroscience 21 19 (2001) 7733-7741
57. Myslobodsky M.S. Anosognosia in tardive dyskinesia: "Tardive dysmentia" or "tardive dementia?". Schizophrenia Bulletin 12 1 (1986) 1-6
58. Nelson H.E. A modified Card Sorting Test sensitive to frontal lobe defect. Cortex 12 (1976) 13-24
59. Novelli G., Papagno C., Capitani E., Laiacona M., Vallar G., and Cappa S.F. Three clinical tests for the assessment of lexical retrieval and production. Norm from 320 normal subjects. Archivio di Psicologia, Neurologia e Psichiatria 47 (1986) 477-506
60. Overall J.E., and Gorham D.R. The brief psychiatric rating scale. Psychological Reports 10 (1962) 799-812
61. Owen A.M., James M., Leigh P.N., Summers B.A., Marsden C.D., Quinn N.P., Lange K.W., et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 115 6 (1992) 1727-1751
62. Pahwa R., and Koller W.C. Advances in the treatment of Parkinson's disease. Drugs Today (Barc) 34 2 (1998) 95-105
63. Paus T., Petrides M., Evans A.C., and Meyer E. Role of the human anterior cingulate cortex in the control of oculomotor, manual, and speech responses: A positron emission tomography study. Journal of Neurophysiology 70 2 (1993) 453-569
64. Pezzella F.R., Di Rezze M., Chianese M., Fabbrini G., Vanacore N., Colosimo C., and Meco G. Hedonistic homeostatic dysregulation in Parkinson's disease: A short screening questionnaire. Neurological Science 24 (2003) 205-206
65. Pluck G.C., and Brown R.G. Apathy in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 73 (2002) 636-642
66. Posner M.I., Petersen S.E., Fox P.T., and Raichle M.E. Localization of cognitive operations in the human brain. Science 240 4859 (1988) 1627-1631
67. Ramaker C., Marinus J., Stiggelbout A.M., and Van Hilten B.J. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Movement Disorders 17 5 (2002) 867-876
68. Raskin S.A., Borod J.C., and Tweedy J. Neuropsychological aspects of Parkinson's disease. Neuropsychological Review 1 3 (1990) 185-221
69. Ridenour T.A., and Dean T.S. Parkinson's disease and neuropsychological assessment. International Journal of Neuroscience 99 1-4 (1999) 1-18
70. Seltzer B., Vasterling J.J., Mathias B.A., and Brennan A. Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer disease and Parkinson disease: A comparative study. Neuropsychiatry, Neuropsychology, and Behavioural Neurology 14 (2001) 122-129
71. Shenker J.I., Wylie S.A., Fuchs K., Manning C.A., and Heilman K.M. On-line anosognosia: Unawareness for chorea in real time but not on videotape delay. Neurology 63 1 (2004) 159-160
72. Snowden J.S., Craufurd D., Griffiths H.L., and Neary D. Awareness of involuntary movements in Huntington disease. Archives of Neurology 55 6 (1998) 801-805
73. Starkstein S.E., Mayberg H.S., Preziosi T.J., Andrezejewski P., Leiguarda R., and Robinson R.G. Reliability, validity and clinical correlates of apathy in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences 4 (1992) 134-139
74. Starkstein S.E., Sabe L., Petracca G., Chemerinski E., Kuzis G., Morello M., and Leiguarda R. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia. Journal of Neurology, Neurosurgery and Psychiatry 61 (1996) 381-387
75. Taylor A.E., Saint-Cyr J.A., and Lang A.E. Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. Brain 109 5 (1986) 845-883
76. Turken A.U., and Swick D. Response selection in the human anterior cingulate cortex. Nature Neuroscience 2 10 (1999) 920-924
77. Vitale C., Pellecchia M.T., Grossi D., Fragassi N., Cuomo T., Di Maio L., and Barone P. Unawareness of dyskinesias in Parkinson's and Huntington's diseases. Neurological Science 22 (2001) 105-106
78. Wechsler D. Wechsler Memory Scale-Revised manual (1987), The Psychological Corporation, San Antonio
79. Weinstein E.A., and Kahn R.L. The syndrome of anosognosia. AMA Archives of Neurology and Psychiatry 64 6 (1950) 772-791
80. Zgaljardic D.J., Borod J.C., Foldi N.S., and Mattis P. A review of the cognitive and behavioural sequelae of Parkinson's disease: Relationship to frontostriatal circuitry. Cognitive and Behavioural Neurology 16 (2003) 193-210